Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

People living with type 2 diabetes face several significant health challenges. The condition, which affects more than 10% of ...

An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk of heart attack, stroke, heart failure and death due to cardiovascular ...

The number of people living with diabetes worldwide has quadrupled in the past two decades, with 830 million people diagnosed ...

Global diabetes rates quadrupled since 1990, affecting 828 million adults, with treatment disparities persisting.

An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk ...

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...

KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...

The International Diabetes Federation (IDF) is drawing up new guidelines for the treatment of Type 2 diabetes in consultation with a global expert panel. These guidelines are being evaluated ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.